CYP2A6 and hepatocellular carcinoma: Additionally, HCC patients with low CYP2A6 and CYP2C8 levels in tumor tissues had higher risk of vascular invasion, major portal vein invasion, and intrahepatic metastasis (all P < 0.05, Table 2).